Covers generation of CEA-specific CAR-expressing NK cells from engineered human embryonic stem cells and their anti-colorectal cancer activity in models.
Key Takeaways
- You have multiple emails registered with Frontiers: You don't have a Frontiers account ?
- Novel renewable immune cell sources are urgently needed to improve tumor treatment outcomes
- Present study aimed to establish a scalable source of CEA-targeted natural killer (NK)